Vectors Research Management, LLC Bristol Myers Squibb CO Transaction History

Vectors Research Management, LLC

  • $285 Million
  • Q1 2025

A detailed history of Vectors Research Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Vectors Research Management, LLC holds 13,000 shares of BMY stock, worth $613,860. This represents 0.28% of its overall portfolio holdings.

Number of Shares
13,000
Previous 13,247 1.86%
Holding current value
$613,860
Previous $749,000 5.74%
% of portfolio
0.28%
Previous 0.26%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 23, 2025
SELL
$53.9 - $63.11 $13,313 - $15,588
-247 Reduced 1.86%
13,000 $792,000
Q1 2024

May 14, 2024
SELL
$47.98 - $54.4 $8,780 - $9,955
-183 Reduced 1.36%
13,247 $718,000
Q4 2023

Feb 12, 2024
SELL
$48.48 - $57.85 $2,230 - $2,661
-46 Reduced 0.34%
13,430 $696,000
Q3 2023

Nov 09, 2023
SELL
$57.89 - $64.73 $17,367 - $19,419
-300 Reduced 2.18%
13,476 $782,000
Q2 2023

Aug 08, 2023
SELL
$63.71 - $70.74 $15,608 - $17,331
-245 Reduced 1.75%
13,776 $881,000
Q1 2023

May 04, 2023
SELL
$65.71 - $74.53 $5,848 - $6,633
-89 Reduced 0.63%
14,021 $972,000
Q4 2022

Feb 08, 2023
BUY
$68.48 - $81.09 $3,150 - $3,730
46 Added 0.33%
14,110 $1.02 Million
Q3 2022

Nov 08, 2022
SELL
$0.13 - $76.84 $152 - $90,363
-1,176 Reduced 7.72%
14,064 $1 Million
Q2 2022

Aug 12, 2022
BUY
$72.62 - $79.98 $77,485 - $85,338
1,067 Added 7.53%
15,240 $1.17 Million
Q1 2022

May 16, 2022
SELL
$61.48 - $73.72 $4,488 - $5,381
-73 Reduced 0.51%
14,173 $1.04 Million
Q2 2021

Aug 09, 2021
BUY
$61.91 - $67.42 $4,519 - $4,921
73 Added 0.52%
14,246 $951,000
Q1 2021

May 18, 2021
BUY
$59.34 - $66.74 $5,934 - $6,673
100 Added 0.71%
14,173 $895,000
Q4 2020

Feb 09, 2021
BUY
$57.74 - $65.43 $52,370 - $59,345
907 Added 6.89%
14,073 $873,000
Q3 2020

Nov 16, 2020
SELL
$57.43 - $63.64 $40,775 - $45,184
-710 Reduced 5.12%
13,166 $788,000
Q2 2020

Aug 13, 2020
BUY
$54.82 - $64.09 $22,476 - $26,276
410 Added 3.04%
13,876 $816,000
Q1 2020

May 14, 2020
SELL
$46.4 - $67.43 $4,640 - $6,743
-100 Reduced 0.74%
13,466 $751,000
Q4 2019

Feb 14, 2020
BUY
$49.21 - $64.19 $22,144 - $28,885
450 Added 3.43%
13,566 $871,000
Q3 2019

Nov 15, 2019
SELL
$42.77 - $50.71 $32,505 - $38,539
-760 Reduced 5.48%
13,116 $665,000
Q2 2019

Aug 12, 2019
SELL
$44.62 - $49.34 $669 - $740
-15 Reduced 0.11%
13,876 $629,000
Q1 2019

Jul 15, 2019
BUY
$45.12 - $53.8 $591,162 - $704,887
13,102 Added 1660.58%
13,891 $663,000
Q4 2018

Feb 13, 2019
SELL
$48.76 - $63.23 $639,779 - $829,640
-13,121 Reduced 94.33%
789 $41,000
Q3 2018

Nov 15, 2018
BUY
$55.19 - $62.25 $767,692 - $865,897
13,910 New
13,910 $768,000

Others Institutions Holding BMY

# of Institutions
2,801
Shares Held
1.59B
Call Options Held
25.9M
Put Options Held
23.9M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $100B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Vectors Research Management, LLC Portfolio

Follow Vectors Research Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vectors Research Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vectors Research Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email